December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

105.57 -0.49 (-0.47%)
Streaming Delayed Price Updated: 1:17 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
Herkimer College Pioneers New AI-Business Degree to Forge Future-Ready Workforce
Herkimer, NY – November 7, 2025 – In a significant move signaling a proactive response to the escalating demand for artificial intelligence (AI) expertise in the business world, Herkimer County... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug ↗
Via Stocktwits
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
3 Dirt Cheap Stocks to Buy With $1,000 Right Now ↗
The overall market may be priced very richly here, but a handful of names haven't been swept up in artificial intelligence (AI)-driven mania. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
2 Safe-and-Steady Stocks Worth Your Attention and 1 We Turn Down
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
ESG Investing's Future: Navigating Regulatory Currents and Sustainable Fund Performance
November 6, 2025 – Environmental, Social, and Governance (ESG) investing finds itself at a pivotal juncture, grappling with a complex web of evolving global regulations and shifting political... 
Via MarketMinute
Topics Artificial Intelligence Bonds Climate Change
News headline image
Navigating the Volatility: Q3 2025 Earnings Season Delivers Both Cheers and Concerns
The third-quarter 2025 earnings season, largely drawing to a close in early November, has proven to be a dynamic and often surprising period for investors. While a significant majority of S&P 500... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025.... 
Via MarketMinute
Topics Intellectual Property
News headline image
Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Case for Dividend Investors ↗
Build a resilient dividend portfolio with Merck (MRK). It offers a strong 3.86% yield, consistent growth, and is backed by top-tier profitability and financial health. 
Via Chartmill
News headline image
3 Reasons Investors Love Merck (MRK)
Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500’s 21.3% return during that period. This may have investors wondering how to... 
Via StockStory
Topics Stocks Supply Chain
News headline image
MarketMinute: The Rise of Precision Swine Farming – A New Frontier in Agri-Tech Investment
The global agricultural landscape is undergoing a profound transformation, with specialized niche markets emerging as significant drivers of innovation and investment. Among these, the precision swine... 
Via MarketMinute
Topics Artificial Intelligence Supply Chain
News headline image
Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars
The burgeoning market for obesity and diabetes treatments, particularly GLP-1 receptor agonists, is witnessing a dramatic divergence in fortunes among its leading players. As of November 5, 2025, Novo... 
Via MarketMinute
Topics Economy
News headline image
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Why Merck Is Sinking This Week ↗
Investors were unimpressed with Merck's Q3 financial results. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
From Merck & Co., Inc.
Via Business Wire
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
With yields of up to 7%, this trio of high-yield stocks are all industry-leading companies. 
Via The Motley Fool
Topics Energy Stocks
News headline image
Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.
From Merck Sharp & Dohme
Via Business Wire
News headline image
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
The biopharmaceutical industry is undergoing an immediate and profound transformation, as Artificial Intelligence (AI) rapidly compresses timelines, drastically reduces costs, and significantly... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
News headline image
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant... 
Via MarketMinute
Topics Intellectual Property
News headline image
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of... 
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
News headline image
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
News headline image
Merck Q3 2025 Earnings Call Transcript ↗
Merck Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush. 
Via Benzinga
Topics ETFs
News headline image
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome... 
Via Benzinga
Topics Economy
News headline image
Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit Outlook ↗
Merck shares dipped after strong earnings and higher profit guidance, as the company narrowed its 2025 sales forecast amid mixed product performance. 
Via Benzinga
News headline image
Merck’s (NYSE:MRK) Q3 Sales Top Estimates
Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.7% year on year to $17.28 billion. The company expects the full year’s revenue to be... 
Via StockStory
News headline image
Merck & Co. Inc. (NYSE:MRK) Q3 2025 Earnings Beat Expectations Despite Stock Decline ↗
Merck Q3 2025 earnings beat estimates with strong sales and EPS growth, driven by KEYTRUDA and WINREVAIR, yet shares fell on guidance. 
Via Chartmill
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.